MERCK CMV MK-8228 LET (Kidney Transplant) - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
- Have had or will have a kidney transplant within 7 days of signing up for the study
What is Involved?
If you choose to join this study, you will:
- Be randomized (like flipping a coin) to Group 1 or Group 2
-- Group 1 will get the study drug, Letermovir (LET)
-- Group 2 will get the standard of care medicine, Valganciclovir (VGCV)
- Both groups will also be asked to give blood